BRIEF-MHRA Says Licensed Brensocatib as First Drug for Non-Cystic Fibrosis Bronchiectasis in Patients Aged 12+

Reuters
Yesterday
BRIEF-MHRA Says Licensed Brensocatib as First Drug for Non-Cystic Fibrosis Bronchiectasis in Patients Aged 12+

Feb 23 (Reuters) - MHRA:

  • MHRA: BRENSOCATIB LICENSED AS FIRST MEDICINE SPECIFICALLY DESIGNED TO TREAT NON-CYSTIC FIBROSIS BRONCHIECTASIS IN PATIENTS 12 YEARS AND OLDER

Source text: [ID:]

Further company coverage: INSM.O

((Reuters.Briefs@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10